Literature DB >> 23456920

A modular design of low-background bioassays based on a high-affinity molecular pair barstar:barnase.

Varun K A Sreenivasan1, Timothy A Kelf, Ekaterina A Grebenik, Oleg A Stremovskiy, Jana M Say, James R Rabeau, Andrei V Zvyagin, Sergey M Deyev.   

Abstract

High-affinity molecular pairs provide a convenient and flexible modular base for the design of molecular probes and protein/antigen assays. Specificity and sensitivity performance indicators of a bioassay critically depend on the dissociation constant (K(D)) of the molecular pair, with avidin:biotin being the state-of-the-art molecular pair (K(D) ∼ 1 fM) used almost universally for applications in the fields of nanotechnology and proteomics. In this paper, we present an alternative high-affinity protein pair, barstar:barnase (K(D) ∼ 10 fM), which addresses several shortfalls of the avidin:biotin system, including non-negligible background due to the non-specific binding. A quantitative assessment of the non-specific binding carried out using a model assay revealed inherent irreproducibility of the [strept]avidin:biotin-based assays, attributed to the avidin binding to solid phases, endogenous biotin molecules and serum proteins. On the other hand, the model assays assembled via a barstar:barnase protein linker proved to be immune to such non-specific binding, showing good prospects for high-sensitivity rare biomolecular event nanoproteomic assays.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456920     DOI: 10.1002/pmic.201200491

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  3 in total

1.  CID fragmentation, H/D exchange and supermetallization of Barnase-Barstar complex.

Authors:  Yury Kostyukevich; Aleksej A Shulga; Alexey Kononikhin; Igor Popov; Eugene Nikolaev; Sergey Deyev
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

2.  Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis.

Authors:  Paul C Trippier; Kevin Tianmeng Zhao; Susan G Fox; Isaac T Schiefer; Radhia Benmohamed; Jason Moran; Donald R Kirsch; Richard I Morimoto; Richard B Silverman
Journal:  ACS Chem Neurosci       Date:  2014-07-18       Impact factor: 4.418

Review 3.  New Frontiers in Diagnosis and Therapy of Circulating Tumor Markers in Cerebrospinal Fluid In Vitro and In Vivo.

Authors:  Olga A Sindeeva; Roman A Verkhovskii; Mustafa Sarimollaoglu; Galina A Afanaseva; Alexander S Fedonnikov; Evgeny Yu Osintsev; Elena N Kurochkina; Dmitry A Gorin; Sergey M Deyev; Vladimir P Zharov; Ekaterina I Galanzha
Journal:  Cells       Date:  2019-10-02       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.